论文部分内容阅读
目的:分析探讨临床静脉药物不合理配伍现象及相应防范对策。方法:选择2015年6月至2016年8月我静脉药物配制中心行常规配伍干预的静脉输液医嘱2000份,设为干预前组,归纳总结不合理配伍医嘱所占比例,并制定防范对策。选取2016年9月至2017年6月干预后的我中心同类型医嘱2000份,设为干预后组,对比干预前后不合理配伍现象改善情况。结果:统计干预前组2000份静脉药物配置不合理医嘱情况,共61份,占3.1%,包括药物溶剂选择不合适、药物配伍禁忌等。干预后组静脉药物配置不合理医5份,占0.25%,组间对比具统计学差异(P<0.05)。结论:针对临床不合理静脉药物配伍的现象,静脉药物配置中心需积极对原因进行分析,制定针对性预防对策,确保医嘱合理准确,对不合理的医嘱及时纠正,以保障患者用药安全。
Objective: To analyze and discuss the unreasonable compatibility of clinical intravenous drugs and corresponding countermeasures. Methods: From June 2015 to August 2016, 2000 venous transfusion medical advice of our venous medicine preparation center was routinely used as intervention group, which was selected as the intervention group. The proportion of unreasonable prescriptions was summed up and preventive measures were formulated. Select the Center from 2000 September to June 2017 after the intervention of the same type of doctor’s advice 2000, set as the intervention group, comparing the phenomenon of unreasonable compatibility before and after intervention to improve the situation. Results: In the pre-intervention group, there were 61 cases (accounting for 3.1%) of the 2000 cases of unreasonable medical prescriptions, including inappropriate choice of drug solvents, incompatibility of drugs and so on. Intravenous drug allocation in the intervention group after unreasonable medical 5, accounting for 0.25%, statistically significant differences between groups (P <0.05). Conclusion: In view of the phenomenon of incompatible clinical venous drug compatibility, venous drug distribution center should actively analyze the causes, formulate targeted preventive measures to ensure reasonable and accurate medical orders, and promptly correct unreasonable medical orders so as to ensure the safety of patients.